Luca Tagliaferri, MD, Ph.D., graduated in Medicine and Surgery at Università Cattolica del Sacro Cuore in Rome and then completed a radiation oncology fellowship. In 2018, he obtained the Associate Professor qualification and in 2021 he obtained the Full Professor qualification (ASN - National Scientific Qualification). He is the Head of the Interventional Radiotherapy Unit at Gemelli-ART (Advanced Radiation Therapy) at Policlinico Universitario Agostino Gemelli-IRCCS (Rome). The focus of his clinical and research activities is head and neck, skin, gynecological and prostate cancer. In addition, he is involved in teaching and medical software development that supports research and clinical practice with a special focus on artificial intelligence. In the European Society for Radiotherapy and Oncology, he chairs the Head & Neck and Skin GEC-ESTRO Working Group and is a member of the GEC-ESTRO committee and guidelines committee. At the Italian Association of Radiation and Clinical Oncology (AIRO), he coordinated activities of the Metabolic Radiotherapy (2015-16) and the Interventional Radiotherapy Working Groups (2018-19). He is a member of the AIRO executive board, currently. His research and clinical activities have led to his authorship in more than 200 papers in peer-reviewed scientific journals and book chapters. He is on the Editorial Board of the Journal of Contemporary Brachytherapy and Brachytherapy.